Stay updated on Nivolumab vs Docetaxel in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Location name updated from Padua, Italy 35128 to Padova, Italy 35128 to reflect local naming and improve accuracy for search and enrollment contacts.
    Difference
    0.0%
    Check dated 2026-04-04T19:11:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T08:50:39.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision label updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears to be a minor software update and does not show changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:33:07.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No visible changes to study content, layout, or navigation are evident on the page.
    Difference
    0.0%
    Check dated 2026-02-05T13:37:25.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Added 'Show glossary' and updated QC-related metadata to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. Removed the previous variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-29T06:36:41.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Docetaxel in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.